<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39333929</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Survival of hospitalised COVID-19 patients in Hawassa, Ethiopia: a cohort study.</ArticleTitle><Pagination><StartPage>1055</StartPage><MedlinePgn>1055</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1055</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09905-w</ELocationID><Abstract><AbstractText>The COVID-19 pandemic, caused by SARS-CoV-2, led to 622,119,701 reported cases and 6,546,118 deaths. Most studies on COVID-19 patients in hospitals are from high-income countries, lacking data for developing countries such as Ethiopia.This study assesses clinical features, demographics, and risk factors for in-hospital mortality in Hawassa, Ethiopia. The research cohort comprises 804 cases exhibiting clinical diagnoses and/or radiological findings and indicative of symptoms consistent with COVID-19 at Hawassa University Comprehensive Specialized Hospital from September 24, 2020, to November 26, 2021. In-hospital mortality rate was predicted using Cox regression. The median age was 45 years, with males making up 64.1% of the population. 173 (21.5%) fatalities occurred, with 125 (72.3%) among males. Male patients had higher mortality rates than females. Severe and critical cases were 24% and 21%. 49.1% had at least one comorbidity, with 12.6% having multiple. Common comorbidities were diabetes (15.9%) and hypertension (15.2%). The Cox regression in Ethiopian COVID-19 patients found that factors like gender, advanced age group, disease severity, symptoms upon admission, shortness of breath, sore throat, body weakness, hypertension, diabetes, multiple comorbidities, and prior health facility visits increased the risk of COVID-19 death, similar to high-income nations. However, in Ethiopia, COVID-19 patients were young and economically active. Patients with at least one symptom had reduced death risk. As a conclusion, COVID-19 in Ethiopia mainly affected the younger demographic, particularly economically active individuals. Early detection can reduce the risk of mortality. Prompt medical attention is essential, especially for individuals with comorbidities. Further research needed on diabetes and hypertension management to reduce mortality risk. Risk factors identified at admission play a crucial role in guiding clinical decisions for intensive monitoring and treatment. Broader risk indicators help prioritize patients for allocation of hospital resources, especially in regions with limited medical facilities. Government's focus on timely testing and strict adherence to regulations crucial for reducing economic impact.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Anteneh</LastName><ForeName>Ali B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Statistics, Hawassa University, Hawassa, Ethiopia. antenehbezabih920@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>LeBlanc</LastName><ForeName>Marissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Institute of Public Health, NIPH, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Natnael</LastName><ForeName>Abebe A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Asfaw</LastName><ForeName>Zeytu Gashaw</ForeName><Initials>ZG</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005002" MajorTopicYN="N" Type="Geographic">Ethiopia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical characteristics</Keyword><Keyword MajorTopicYN="N">Cox proportional hazard</Keyword><Keyword MajorTopicYN="N">Date of admission</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39333929</ArticleId><ArticleId IdType="pmc">PMC11429985</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09905-w</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09905-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Worldometer. COVID-19 coronavirus pandemic. 2023. https://www.worldometers.info/coronavirus/. Accessed Mar 2023.</Citation></Reference><Reference><Citation>Mezgebu TA, Sibhat MM, Getnet MT, Gebeyehu KT, Chane WZ, Getahun EM, Habtamu AS, Asmare HB, Ambaw MM. Risk factors of early mortality among COVID-19 deceased patients in Addis Ababa COVID-19 care centers, Ethiopia. PLoS ONE. 2022;17(9):e0275131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9514640</ArticleId><ArticleId IdType="pubmed">36166445</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2023. https://covid19.who.int/table. Accessed 24 Jan 2024.</Citation></Reference><Reference><Citation>Worldometer. Population of Ethiopia (2020 and historical). 2023. https://www.worldometers.info/world-population/ethiopia-population/. Accessed 24 Jan 2023.</Citation></Reference><Reference><Citation>Worldometer. Coronavirus cases. 2020. https://www.worldometers.info/coronavirus/country/ethiopia/graph-cases-daily. Accessed 15 Feb 2023.</Citation></Reference><Reference><Citation>World Health Organization. Primary health care systems (PRIMASYS): Case study from South Africa. No. WHO/HIS/HSR/17.38. Licence: CC BY-NC-SA 3.0 IGO. 2017.</Citation></Reference><Reference><Citation>Marcus HG, Mehretu A, Crummey DE. "Ethiopia". Encyclopedia Britannica. https://www.britannica.com/place/Ethiopia. Accessed 19 Sept 2024.</Citation></Reference><Reference><Citation>Worldometer. Population of US (historical). 2020. https://www.worldometers.info/world-population/US-population/. Accessed 24 Jan 2020.</Citation></Reference><Reference><Citation>Angaw DA, Ali R, Tadele A, Shumet S. The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies. BMC Cardiovasc Disord. 2021;21(1):1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7814574</ArticleId><ArticleId IdType="pubmed">33461482</ArticleId></ArticleIdList></Reference><Reference><Citation>Maru EH, Leulseged TW, Hassen IS, Zewde WC, Chamesew NW, Abebe DS, Jagema TB, Bayisa AB, Gezahegn MA, Tefera OS, Shiferaw WG. Predictors of death in severe COVID-19 patients at millennium COVID-19 care center in Ethiopia: a case-control study. medRxiv. 2020:2020–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8308857</ArticleId><ArticleId IdType="pubmed">34367430</ArticleId></ArticleIdList></Reference><Reference><Citation>Atamenta T, Cherie A, Alemu W. Time to death and its predictors among adult patients with COVID-19: A retrospective cohort study in Ethiopia. Front Epidemiol. 2023;2:1065184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10911043</ArticleId><ArticleId IdType="pubmed">38455333</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessie AM, Animut Z, Genet A, Yenew C. Incidence of Death and Its Predictors of COVID-19 in Amhara Region. Ethiopia: A Retrospective Follow Up Study. Infect Drug Resist. 2022:4907–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9432381</ArticleId><ArticleId IdType="pubmed">36060235</ArticleId></ArticleIdList></Reference><Reference><Citation>Abebe HT, Zelelow YB, Bezabih AM, Ashebir MM, Tafere GR, Wuneh AD, Araya MG, Kiros NK, Hiluf MK, Ebrahim MM, Gebrehiwot TG. Time to Recovery of Severely Ill COVID-19 Patients and its Predictors: A Retrospective Cohort Study in Tigray, Ethiopia. J Multidiscip Healthc. 2022:1709–18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9377347</ArticleId><ArticleId IdType="pubmed">35979444</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolossa T, Wakuma B, Seyoum Gebre D, Merdassa Atomssa E, Getachew M, Fetensa G, Ayala D, Turi E. Time to recovery from COVID-19 and its predictors among patients admitted to treatment center of Wollega University Referral Hospital (WURH), Western Ethiopia: Survival analysis of retrospective cohort study. PLoS ONE. 2021;16(6):e0252389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8191892</ArticleId><ArticleId IdType="pubmed">34111146</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhems P, Gustin MP, Elias C, Henaff L, Dananche C, Grisi B, Marion E, Khanafer N, Hilliquin D, Gardes S, Gerbier-Colomban S. Factors associated with admission to intensive care units in COVID-19 patients in Lyon-France. PLoS ONE. 2021;16(1):e0243709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7840037</ArticleId><ArticleId IdType="pubmed">33503018</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyeltshen K, Tsheten T, Dorji S, Pelzang T, Wangdi K. Survival analysis of symptomatic COVID-19 in phuentsholing municipality, Bhutan. Int J Environ Res Public Health. 2021;18(20):10929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8535658</ArticleId><ArticleId IdType="pubmed">34682676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijman G, Wientjes M, Ramjith J, Janssen N, Hoogerwerf J, Abbink E, Blaauw M, Dofferhoff T, van Apeldoorn M, Veerman K, de Mast Q. Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis. PLoS ONE. 2021;16(3):e0249231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997038</ArticleId><ArticleId IdType="pubmed">33770140</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vito A, Geremia N, Fiore V, Princic E, Babudieri S, Madeddu G. Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy. Eur Rev Med Pharmacol Sci. 2020:7861–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32744714</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7098485</ArticleId><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge E, Li Y, Wu S, Candido E, Wei X. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. PLoS ONE. 2021;16(10):e0258154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8491945</ArticleId><ArticleId IdType="pubmed">34610047</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa GJ, Garces TS, Cestari VR, Florêncio RS, Moreira TM, Pereira ML. Mortality and survival of COVID-19. Epidemiol Infect. 2020;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7330281</ArticleId><ArticleId IdType="pubmed">32580809</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado-Alba, Jorge Enrique, Luis Fernando Valladales-Restrepo, Manuel Enrique Machado-Duque, Andrés Gaviria-Mendoza, Nicolás Sánchez-Ramírez, Andrés Felipe Usma-Valencia, Esteban Rodríguez-Martínez et al. “Factors associated with admission to the intensive care unit and mortality in patients with COVID-19, Colombia. PLoS ONE. 2021;16(11):e0260169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604321</ArticleId><ArticleId IdType="pubmed">34797857</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza FS, Hojo-Souza NS, Batista BD, da Silva CM, Guidoni DL. On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database. PLoS ONE. 2021;16(3):e0248580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7971705</ArticleId><ArticleId IdType="pubmed">33735272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaso AW, Agero G, Hurissa Z, Kaso T, Ewune HA, Hareru HE, Hailu A. Survival analysis of COVID-19 patients in Ethiopia: a hospital-based study. PLoS ONE. 2022;17(5):e0268280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9084518</ArticleId><ArticleId IdType="pubmed">35533178</ArticleId></ArticleIdList></Reference><Reference><Citation>Leulseged TW, Maru EH, Hassen IS, Zewde WC, Chamiso NW, Abebe DS, Jagema TB, Bayisa AB, Gezahegn MA, Tefera OS, Shiferaw WG. Predictors of death in severe COVID-19 patients at millennium COVID-19 care center in Ethiopia: a case-control study. Pan Afr Med J. 2021;38(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8308857</ArticleId><ArticleId IdType="pubmed">34367430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengist B, Animut Z, Tolossa T. Incidence and predictors of mortality among COVID-19 patients admitted to treatment centers in North West Ethiopia; A retrospective cohort study, 2021. Int J Afr Nurs Sci. 2022;16:100419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9055687</ArticleId><ArticleId IdType="pubmed">35530744</ArticleId></ArticleIdList></Reference><Reference><Citation>Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, Zhang HY, Sun W, Wang Y. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577–83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228329</ArticleId><ArticleId IdType="pubmed">32162702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemma Tirore L, Abose Nadamo S, Tamrat Derilo H, Erkalo D, Sedore T, Tadesse T, Ermias D, Yaekob T. Time to Recovery from COVID-19 and Its Predictors Among Patients Admitted to Treatment Centers of Southern Nations Nationalities and Peoples Region (SNNPR), ETHIOPIA: Multi-Center Retrospective Cohort Study. Infect Drug Resist. 2022:3047–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9209334</ArticleId><ArticleId IdType="pubmed">35747331</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahim SA, Tessema M, Defar A, Hussen A, Ejeta E, Demoz G, Tereda AB, Dillnessa E, Feleke A, Amare M, Nigatu F. Time to recovery and its predictors among adults hospitalized with COVID-19: a prospective cohort study in Ethiopia. PLoS ONE. 2020;15(12):e0244269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773180</ArticleId><ArticleId IdType="pubmed">33378367</ArticleId></ArticleIdList></Reference><Reference><Citation>Churiso G, Diriba K, Girma H, Tafere S. Clinical features and time to recovery of admitted COVID-19 cases at Dilla University Referral Hospital Treatment Center, South Ethiopia. Infect Drug Resist. 2022:795–806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8904438</ArticleId><ArticleId IdType="pubmed">35281575</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110556</ArticleId><ArticleId IdType="pubmed">27352628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, Liu X, Wei L, Truelove SA, Zhang T, Gao W. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185944</ArticleId><ArticleId IdType="pubmed">32353347</ArticleId></ArticleIdList></Reference><Reference><Citation>Osibogun A, Balogun M, Abayomi A, Idris J, Kuyinu Y, Odukoya O, Wright O, Adeseun R, Mutiu B, Saka B, Osa N. Outcomes of COVID-19 patients with comorbidities in southwest Nigeria. PLoS ONE. 2021;16(3):e0248281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7959379</ArticleId><ArticleId IdType="pubmed">33720975</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Voinsky I, Baristaite G, Gurwitz D. Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patients. J Infect. 2020;81(2):e102-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229949</ArticleId><ArticleId IdType="pubmed">32425274</ArticleId></ArticleIdList></Reference><Reference><Citation>Azarkar G, Osmani F. Clinical characteristics and risk factors for mortality in COVID-19 inpatients in Birjand, Iran: a single-center retrospective study. Eur J Med Res. 2021;26(1):1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294317</ArticleId><ArticleId IdType="pubmed">34289910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanpanah Y, French COVID Cohort Investigators and Study Group, RORIZ M, RISPAL P, REDL S, LEFEBVRE L, GRANIER P, MAULIN L, JOSEPH C, MOYET J, LION-DAOLIO S. Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients. J Med Virol. 2021;93(4):2149–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675272</ArticleId><ArticleId IdType="pubmed">33058220</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Xing Y, Jia J, Ni W, Liang J, Zhao D, Song X, Gao R, Jiang F. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. Sci Total Environ. 2020;728:138812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175870</ArticleId><ArticleId IdType="pubmed">32335406</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497–506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi L, Yang Y, Jiang D, Tu C, Wan L, Chen X, Li Z. Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study. Int J Infect Dis. 2020;96:531–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7231495</ArticleId><ArticleId IdType="pubmed">32425636</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, Chen H, Wang D, Liu N, Liu D, Chen G. Characteristics of COVID-19 infection in Beijing. J Infect. 2020;80(4):401–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102527</ArticleId><ArticleId IdType="pubmed">32112886</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S, Xiang YI, Fang W, Zheng Y, Li B, Hu Y, Lang C, Huang D, Sun Q, Xiong Y, Huang X. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797–806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228368</ArticleId><ArticleId IdType="pubmed">32198776</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224340</ArticleId><ArticleId IdType="pubmed">32075786</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges do Nascimento IJ, Cacic N, Abdulazeem HM, Von Groote TC, Jayarajah U, Weerasekara I, Esfahani MA, Civile VT, Marusic A, Jeroncic A, Carvas Junior N. Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J Clin Med. 2020;9(4):941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7230636</ArticleId><ArticleId IdType="pubmed">32235486</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Qiu Z, Liu J, Fan T, Liu C, Tian P, Wang Y, Ni Z, Zhang S, Luo J, Liu D. Analysis of the clinical characteristics of 77 COVID-19 deaths. Sci Rep. 2020;10(1):16384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7532142</ArticleId><ArticleId IdType="pubmed">33009426</ArticleId></ArticleIdList></Reference><Reference><Citation>Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, Angelucci E, Krampera M, Cairoli R, Della Porta MG, Fracchiolla N. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7(10):e737–45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7426107</ArticleId><ArticleId IdType="pubmed">32798473</ArticleId></ArticleIdList></Reference><Reference><Citation>Marschner IC. Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian data. BMC Med Res Methodol. 2021;21(1):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8215490</ArticleId><ArticleId IdType="pubmed">34154563</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Patti G, Hayden E, Azzolina D, Pirisi M, Acquaviva A, Aimaretti G, Aluffi Valletti P, Angilletta R, Arioli R, Avanzi GC. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. Sci Rep. 2020;10(1):20731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7692524</ArticleId><ArticleId IdType="pubmed">33244144</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China Allergy. 2020;75(7):1730–41.</Citation><ArticleIdList><ArticleId IdType="pubmed">32077115</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalili M, Karamouzian M, Nasiri N, Javadi S, Mirzazadeh A, Sharifi H. Epidemiological characteristics of COVID-19: a systematic review and meta-analysis. Epidemiol Infect. 2020;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7343974</ArticleId><ArticleId IdType="pubmed">32594937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim BL, Chidambaram SK, Wong XC, Pathmanathan MD, Peariasamy KM, Hor CP, Chua HJ, Goh PP. Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study. Lancet Reg Health-West Pac. 2020;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837062</ArticleId><ArticleId IdType="pubmed">33521741</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker R, Kristofferson AB, Salamanca BV, Seppälä E, Golestani K, Kvåle R, Watle SV, Buanes EA. Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients. Clin Microbiol Infect. 2022;28(6):871–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8872711</ArticleId><ArticleId IdType="pubmed">35219807</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L, Cai J, Zhang H, Qin Y, Sun H, Ding W. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4):e1008520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7209966</ArticleId><ArticleId IdType="pubmed">32343745</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassar Y, Ahmed M, Amr El, Marwa Elsaye, Farouk Mostafa, Ashraf Rady, Akram Eladawy et al. Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study. J Infect Public Health 2021;14(10):1381–1388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233058</ArticleId><ArticleId IdType="pubmed">34215561</ArticleId></ArticleIdList></Reference><Reference><Citation>El Aidaoui K, Haoudar A, Khalis M, Kantri A, Ziati J, El Ghanmi A, Bennis G, El Yamani K, Dini N, El Kettani C. Predictors of severity in Covid-19 patients in Casablanca, Morocco. Cureus. 2020;12(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7532862</ArticleId><ArticleId IdType="pubmed">33033687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chastain DB, Osae SP, Thomas GM, Burt AM, Rao A, Henao-Martínez AF, Franco-Paredes C, Waller JL, Young HN. Clinical Severity on Hospital Admission for COVID-19: An Analysis of Social Determinants of Health From an Early Hot Spot in the Southeastern US. J Prim Care Community Health. 2022;13:21501319221092244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9016530</ArticleId><ArticleId IdType="pubmed">35426348</ArticleId></ArticleIdList></Reference><Reference><Citation>Günster C, Busse R, Spoden M, Rombey T, Schillinger G, Hoffmann W, Weber-Carstens S, Schuppert A, Karagiannidis C. 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany. PLoS ONE. 2021;16(8):e0255427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8341502</ArticleId><ArticleId IdType="pubmed">34351975</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region. Italy JAMA. 2020;323(16):1574–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC COVID-19 Response Team, CDC COVID-19 Response Team, CDC COVID-19 Response Team, Bialek S, Boundy E, Bowen V, Chow N, Cohn A, Dowling N, Ellington S, Gierke R. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States, February 12-March 16, 2020. Morb Mortal Wkly Rep. 2020;69(12):343–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725513</ArticleId><ArticleId IdType="pubmed">32214079</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, Liu S, Yang JK. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020:152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu DI, Guo W, Cao Y, Huang D, Wang H, Wang T, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizuorno A, Fierro NA, Copado-Villagrana ED, Herrera-Solís ME, Oskrochi G, Brim H, Ashktorab H. COVID-19 and gastrointestinal symptoms in Mexico, a systematic review: does location matter? BMC Infect Dis. 2021;21(1):1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193163</ArticleId><ArticleId IdType="pubmed">34116647</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China JAMA. 2020;323(11):1061–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu DI, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig. 2020;130(5):2620–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong S, Liu L, Lin F, Shi J, Han L, Liu H, He L, Jiang Q, Wang Z, Fu W, Li Z. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study. BMC Infect Dis. 2020;20:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7578439</ArticleId><ArticleId IdType="pubmed">33092539</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, Tang C, Sang L, Liu J, Ni Z, Hu Y. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest. 2020;158(1):97–105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158802</ArticleId><ArticleId IdType="pubmed">32304772</ArticleId></ArticleIdList></Reference><Reference><Citation>Impouma B, Carr AL, Spina A, Mboussou F, Ogundiran O, Moussana F, Williams GS, Wolfe CM, Farham B, Flahault A, Tores CC. Time to death and risk factors associated with mortality among COVID-19 cases in countries within the WHO African region in the early stages of the COVID-19 pandemic. Epidemiol Infect. 2022;150:e73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9002149</ArticleId><ArticleId IdType="pubmed">35177157</ArticleId></ArticleIdList></Reference><Reference><Citation>South Africa Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases et al. Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis 2021;73(7):e2005–e2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499501</ArticleId><ArticleId IdType="pubmed">32860699</ArticleId></ArticleIdList></Reference><Reference><Citation>Telle KE, Grøsland M, Helgeland J, Håberg SE. Factors associated with hospitalization, invasive mechanical ventilation treatment and death among all confirmed COVID-19 cases in Norway: Prospective cohort study. Scand J Public Health. 2021;49(1):41–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33461404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bepouka B, Mayasi N, Mandina M, Longokolo M, Odio O, Mangala D, Mbula M, Kayembe JM, Situakibanza H. Risk factors for mortality in COVID-19 patients in sub-Saharan Africa: A systematic review and meta-analysis. PLoS ONE. 2022;17(10):e0276008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9576083</ArticleId><ArticleId IdType="pubmed">36251715</ArticleId></ArticleIdList></Reference><Reference><Citation>Izizag BB, Madone M, Makulo JR, Murielle L, Ossam O, Nadine M, Tresor P, Godelive N, Felly T, Donatien M, Dupont M. Predictors of mortality in COVID-19 patients at Kinshasa University Hospital, Democratic Republic of the Congo, from March to June 2020. Pan Afr Med J. 2020;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7757324</ArticleId><ArticleId IdType="pubmed">33425138</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>